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Introduction
In neurosecretory cells, secretory granules (SGs) containing 
neuropeptides and hormones fuse with the plasma membrane 
and release their contents into the extracellular space (Bader 
et al., 2002; Dernick et al., 2003; Becherer and Rettig, 2006; 
Neher, 2006; Westerink and Ewing, 2008). Before undergoing 
exocytosis, SGs need to pass through the physical barrier im-
posed by the cortical actin network. This network plays a dual 
role in neuroexocytosis. It first acts as a barrier for SGs, which 
is dissipated in response to Ca2+ influx through the action of 
proteins such as scinderins (Vitale et al., 1991; Lejen et al., 
2002). It then plays a more active role, regulated by intersectin-1, 
cdc42 (Gasman et al., 2004; Malacombe et al., 2006), and 
phosphatidylinositol(4,5)bisphosphate (Wen et al., 2011), in 
promoting SG transport to the plasma membrane (Gasman et al., 
2004; Malacombe et al., 2006; Wen et al., 2011). However, the 
mechanism whereby SGs are recruited to the cortical actin 
network and how this process helps to regulate diverse pools 
of SGs are currently unknown. The goal of this study was to 
identify cytosolic proteins that interact with SGs in a Ca2+-
dependent manner, thereby demonstrating the molecular mecha-
nism underlying activity-dependent mobilization of SGs to the 
cortical actin network.
To address this, we established an organelle pull-down 
protocol using purified SGs as bait, coupled to mass spectrome-
try (MS) to identify cytosolic proteins recruited to SGs in a Ca2+-
dependent manner. One of the identified proteins was myosin VI. 
This motor protein is unique as, in addition to playing an im-
portant anchoring role (Self et al., 1999), its directionality 
along actin filaments runs counter to other myosin proteins (Wells 
et al., 1999; Bryant et al., 2007). Four alternatively spliced iso-
forms of myosin VI have been identified containing either a 
large insert (21–31 aa), a small insert (SI; 9 aa), no insert (NI), 
or both inserts within the C-terminal tail, located in the cargo-
binding domain (Buss et al., 2001; Au et al., 2007). These iso-
forms are differentially expressed in tissues and cell lines and 
are associated with specific subcellular compartments and a host 
of cellular functions (Buss et al., 2001; Au et al., 2007; Puri, 2009). 
Before undergoing neuroexocytosis, secretory gran-ules (SGs) are mobilized and tethered to the cor-tical actin network by an unknown mechanism. 
Using an SG pull-down assay and mass spectrometry, 
we found that myosin VI was recruited to SGs in a Ca2+-
dependent manner. Interfering with myosin VI function in 
PC12 cells reduced the density of SGs near the plasma 
membrane without affecting their biogenesis. Myosin VI 
knockdown selectively impaired a late phase of exocytosis, 
consistent with a replenishment defect. This exocytic 
defect was selectively rescued by expression of the 
myosin VI small insert (SI) isoform, which efficiently teth-
ered SGs to the cortical actin network. These myosin VI 
SI–specific effects were prevented by deletion of a c-Src 
kinase phosphorylation DYD motif, identified in silico. 
Myosin VI SI thus recruits SGs to the cortical actin network, 
potentially via c-Src phosphorylation, thereby maintain-
ing an active pool of SGs near the plasma membrane.
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Figure 1. Myosin VI interacts with SGs in a Ca2+-dependent manner. (A) Bovine adrenal medulla fractionation was assessed by SDS-PAGE and Western 
blotting with the indicated antibodies (Golgi: GM130; early endosomes: Rab5; endoplasmic reticulum: protein disulfide-isomerase (PDI); plasma mem-
brane: SNAP25; and SG: Synaptotagmin-I and VAMP2). Purified SGs were obtained by pooling fractions 11 and 12. (B) Schematic representation of 
the experimental approach used to identify cytosolic proteins interacting with SGs in a Ca2+-dependent manner. (C, top) Purified SGs and cytosol were 
incubated in the presence of increasing free [Ca2+]. Myosin VI recruitment to SGs was analyzed by Western blotting. Synaptotagmin-I was used as a 
loading control. (bottom) Quantification of myosin VI recruitment to SGs (n = 3). (D, left) PC12 cells immunolabeled with anti–myosin VI (green) and 
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Although myosin VI has recently been shown to be important 
for synaptic function in the Drosophila melanogaster neuro-
muscular junction (Kisiel et al., 2011), its precise role in neuro-
secretory cells remains to be elucidated, with its involvement 
in regulated secretion in these cells recently being questioned 
(Majewski et al., 2011). Here, we reveal a novel role for the 
myosin VI SI in tethering SGs to F-actin in response to stimula-
tion. We also demonstrate that this process is required for the 
maintenance of regulated neuroexocytosis in PC12 cells and is 
possibly controlled by c-Src kinase through the phosphoryla-
tion of a single DYD motif solely present in this isoform.
Results
Myosin VI interacts with SGs in a  
Ca2+-dependent manner
To identify the cytosolic proteins that are recruited to SGs in a 
Ca2+-dependent manner, purified SGs and cytosol were prepared 
from bovine adrenal medulla (Smith and Winkler, 1967; Simon 
et al., 1988; Meunier et al., 2005). Fractions enriched in SGs (11 
and 12) were identified by the presence of Synaptotagmin-I 
and VAMP2 and pooled (referred to hereafter as purified SGs; 
Fig. 1 A; Brose et al., 1992; Papini et al., 1995). Purified SGs and 
cytosol were then mixed in the presence or absence of 100 µM 
free Ca2+ (Fig. 1 B; Osborne et al., 2008). After washing and solu-
bilization, samples were incubated with ProteoMiner beads to 
increase the detection of low abundance proteins (Bellei et al., 
2011; Fonslow et al., 2011). The eluate from the ProteoMiner 
beads was digested with trypsin and analyzed by MS (Fig. 1 B). 
Identified proteins were classified based on their MS protein 
score with or without Ca2+ (Table S1). One interesting cytosolic 
protein, the score of which was highly increased in the presence 
of Ca2+, was myosin VI (Table 1). The Ca2+-dependent recruit-
ment of myosin VI to purified SGs was confirmed by Western 
blotting (Fig. 1 C). We also analyzed the colocalization between 
Synaptotagmin-1–labeled SGs and either myosin VI, EEA1 (an 
early endosome marker), or VAMP2 in PC12 cells (Fig. 1 D). 
This analysis revealed a threefold higher Pearson correlation 
coefficient between myosin VI/Synaptotagmin-l compared with 
EEA1/Synaptotagmin-1 (P < 0.001). The association of myo-
sin VI with SGs was also confirmed using immunoelectron 
microscopy (Fig. 1 E, 2.48% SG myosin VI positive compared 
with 0.65% for control IgG).
Myosin VI tethers SGs to the cortical 
actin network in PC12 cells and is required 
to sustain regulated exocytosis
To analyze the role of myosin VI in the SG dynamics and regu-
lated exocytosis in PC12 cells, we reduced its expression level 
using an shRNA knockdown strategy. Two different shRNAs 
(sh2- and sh3-RNA), which target highly conserved N-terminal 
sequences present in all myosin VI isoforms, were used. Using 
these shRNAs, total myosin VI expression was depleted by 
50–60% compared with untransfected cells or a scrambled se-
quence (Fig. 2 A). Using total internal reflection fluorescence 
(TIRF) microscopy, we analyzed the distribution and movement 
of SGs after myosin VI knockdown in cells expressing neu-
ropeptide Y (NPY)-mCherry, as an SG marker. Myosin VI 
knockdown significantly reduced the number of SGs near the 
plasma membrane both before and after nicotine stimulation 
(Fig. 2, B and C) but did not affect the average speed of the 
SGs (Fig. 2 D). This suggested that reduced myosin VI expres-
sion results in either a defect in the retention of SGs near the 
plasma membrane or a reduction in SG biogenesis. However, 
myosin VI knockdown did not affect the level (Fig. S1 A) or 
distribution of Synaptotagmin-l (Fig. S1 B). Furthermore, the 
Golgi complex morphology (Fig. S1 C) was not perturbed, sug-
gesting that the reduced SG density detected in the TIRF region 
of myosin VI knockdown cells results from a defect in SG an-
choring to the cortical actin network rather than from decreased 
SG biogenesis.
Given the lack of effect on the average speed of SGs 
(Fig. 2 D), myosin VI is unlikely to be implicated in generating 
their movement but could be involved in tethering SG to the 
cortical actin network as they are progressing toward the plasma 
membrane. To test this hypothesis, we analyzed a selected popu-
lation of nonresident SGs appearing in the TIRF plane and 
undergoing movement toward the plasma membrane. The mean 
anti–Synaptotagmin-I (red) antibodies. Arrows mark colabeled SGs. The enlarged images (insets) show the association between endogenous myosin VI 
and Synaptotagmin-I. Bars: (main images) 5 µm; (insets) 1 µm. (right) Analysis of the colocalization between Synaptotagmin-I (Syt-I) and myosin VI, EEA1, 
or VAMP2. (E) Paraformaldehyde-fixed PC12 cells were immunolabeled with the anti–myosin VI antibody and labeled with 5-nm protein A–gold for EM. 
Arrowheads show myosin VI–positive SGs. Error bars are means ± SEM. *, P < 0.05; **, P < 0.01; ***, P < 0.001.
 
Table 1. Myosin VI peptide sequence obtained from peptide mass and fragmentation data analysis
Myosin VI peptides Observed Experimental Mr Calculated Mr ppm Miss Score
D.LKENIAIVER.R + deamidated (NQ) 1,185.6534 1,184.6462 1,184.6764 25.55 1 44
T.RMQAQARGQLMR.I + three  
deamidated (NQ); two oxidation (M)
1,480.7603 1,479.753 1,479.6922 41.10 2 29
S.LQSLLKDTQIQLDDAVR.A + three  
deamidated (NQ)
1,958.9742 1,957.9669 1,958.0208 27.51 1 31
S.SFQTVSALHRENLNKLMTNLR.T +  
deamidated (NQ)
2,473.2018 2,472.1945 2,472.2907 38.91 2 22
A Mascot ion score >25 represents a peptide with an extensive homology to the sequence in the database. Mr, related molecular weight; ppm, parts per million mass 
accuracy; Miss, number of missed tryptic cleavages; Score, Mascot ion score.
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Figure 2. Myosin VI knockdown impairs the maintenance of exocytosis. (A, left) Analysis of myosin VI expression levels by Western blotting with an 
anti–myosin VI antibody in untransfected PC12 cells, cells transfected with GFP-scrambled shRNA (control), and cells transfected with GFP-shRNA against 
myosin VI (GFP–sh2-RNA and GFP–sh3-RNA). Anti–-actin was used as a loading control. (right) Quantification of the expression level of myosin VI (n = 6). 
(B) TIRF images of NPY-mCherry (pseudocolored gray) in PC12 cotransfected with GFP–scrambled-shRNA (control), GFP–sh2-RNA, or GFP–sh3-RNA. Left 
insets show the respective GFP-shRNA expression. The enlarged images on the right highlight a fixed area for comparison of SG density. Bars: (main 
images and left insets) 5 µm; (right insets) 1 µm. (C and D) SG density (C) and SG average speed (D) in the TIRF plane quantified in the condition shown 
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the first round of stimulation (15 min; Fig. 3 D). This potenti-
ating effect was maintained after a second round of stimula-
tion (45 min; Fig. 3 D) and was specific for the myosin VI SI 
isoform, as we did not observe any change in evoked release 
upon GFP-MyoVI-NIfull expression (Fig. 3 D).
We next performed rescue experiments in myosin VI 
stable knockdown PC12 cells and evaluated the NPY-hPLAP–
evoked release upon reexpression of the different isoforms. 
We found that expression of GFP-MyoVI-SIfull, but not GFP-
MyoVI-NIfull, was sufficient to rescue stimulated exocytosis 
(Fig. 3 E), confirming a specific role for myosin VI SI in the 
maintenance of regulated exocytosis in neurosecretory cells. 
To elucidate whether the mechanism underpinning this iso-
form-specific function relied on the ability of myosin VI SI to 
anchor SGs to the cortical actin network, we used TIRF micros-
copy to analyze the motility of SGs in myosin VI knockdown 
cells expressing NPY-mCherry alone (myosin VI knockdown) 
or after expression of GFP-MyoVI-SIfull or GFP-MyoVI-NI-
full (Fig. 4, A and B). Strikingly, the trajectories of SGs asso-
ciated with GFP-MyoVI-SIfull (GFP-MyoVI-SIfull–positive 
SGs) were highly confined when compared with those not 
associated with GFP-MyoVI-SIfull (GFP-MyoVI-SIfull–
negative SGs; Fig. 4, A, C, and E; and Video 1) or associated 
with GFP-MyoVI-NIfull (GFP-MyoVI-NIfull–positive SGs; 
Fig. 4, B, D, and F; and Video 2). Collectively, these data 
point toward an anchoring role for myosin VI SI in tethering 
SGs near the plasma membrane.
We predicted that expression of N-terminal deletion mu-
tants (GFP-MyoVI-tails; Fig. 3 B), lacking the ability to interact 
with actin (Mermall et al., 1998; Wells et al., 1999; Krendel 
and Mooseker, 2005), should alter the behavior of SGs at the 
plasma membrane by acting in a dominant-negative manner. 
PC12 cells coexpressing NPY-mCherry with either GFP (control), 
GFP-MyoVI-SIfull, GFP-MyoVI-NIfull, GFP-myosin VI SI 
tail (GFP-MyoVI-SItail), or GFP-myosin VI NI tail (GFP-MyoVI-
NItail) were imaged by TIRF microscopy (Fig. 5 A). Neither 
GFP-MyoVI-SIfull nor GFP-MyoVI-NIfull expression affected 
SG density near the plasma membrane compared with control 
(Fig. 5 B). In contrast, expression of GFP-MyoVI-SItail, but not 
GFP-MyoVI-NItail, significantly reduced SG density both be-
fore and after stimulation when compared with control cells 
or cells expressing GFP-MyoVI-SIfull (Fig. 5 B). Consistent 
with a role for myosin VI in anchoring SGs to the cortical 
actin network, the average speed of the SGs was significantly 
increased when either GFP-MyoVI-SItail or GFP-MyoVI-NItail 
was expressed (Fig. 5 C). These results highlight the impor-
tance of the interaction between myosin VI and F-actin in reg-
ulating the tethering of SGs to the cortical actin network.
square displacement (MSD) was evaluated in control and 
myosin VI knockdown PC12 cells after stimulation (Fig. 2 E). 
In myosin VI knockdown PC12 cells, this population of SGs 
exhibited a significantly higher MSD (GFP–sh2-RNA: 3.79 ± 
0.90 µm2; GFP–sh3-RNA: 3.61 ± 0.57 µm2; Fig. 2 E) than in 
control cells (1.32 ± 0.52 µm2) after 12 s of tracking. As SGs 
approaching the plasma membrane show much less restricted 
movement in the absence of myosin VI, we hypothesized that 
myosin VI was involved in tethering and retention of SGs within 
this region, thus contributing to the maintenance of SG density 
in the cortical region of neurosecretory cells.
To evaluate whether reduced SG density near the plasma 
membrane impacts on neuroexocytosis, we measured stimulated 
NPY–human placental alkaline phosphatase (hPLAP) release. 
Although we did not observe any significant effect of myosin 
VI knockdown after 15-min stimulation, there was a clear reduc-
tion in the evoked release after restimulation with fresh high 
K+ for a further 45 min (Fig. 2 F and Fig. S2 A). We found that 
the duration of stimulation was paramount in the detection of 
the exocytic phenotype. Indeed, long-term TIRF imaging of NPY-
mCherry–labeled SGs from myosin VI stable knockdown cells 
(Fig. 2 G) clearly showed that the density of SGs steadily de-
creased with prolonged stimulation, an effect that was not de-
tected in control cells (Fig. 2 H and Fig. S2 B). Myosin VI 
knockdown therefore promotes a defect in the recruitment 
and retention of SGs to the cortical actin network. Collectively, 
our data demonstrate that by retaining SGs in the cortical actin 
network, myosin VI plays an important role in the replenish-
ment and maintenance of an active pool of SGs, required to sus-
tain neuroexocytosis.
Myosin VI SI isoform regulates  
activity-dependent recruitment of SGs to 
the cortical actin network and exocytosis 
in PC12 cells
We confirmed that the myosin VI NI and SI isoforms were 
present in PC12 cells (Fig. 3 A). To assess the involvement 
of the different isoforms in neuroexocytosis, PC12 cells co-
expressing NPY-hPLAP with either GFP (control), GFP-myosin 
VI SI full length (GFP-MyoVI-SIfull; Fig. 3 B), or GFP-myosin 
VI NI full length (GFP-MyoVI-NIfull; Fig. 3 B) were stimu-
lated with high K+, and NPY release was measured. Impor-
tantly, these proteins showed comparable expression levels 
(Fig. 3 C). The release assay showed that GFP-MyoVI-SIfull 
expression potentiated the evoked release of NPY by 58% 
when compared with that of stimulated control cells (17% 
NPY-hPLAP release in control cells vs. 27% NPY-hPLAP re-
lease in GFP-MyoVI-SIfull–expressing cells) in response to 
in B before and after 100 µM nicotine stimulation. (E) Average MSD of tracked NPY-mCherry–positive SG appearing in the TIRF plane and moving toward 
the plasma membrane in the conditions shown in B, after nicotine stimulation, over 12 s of tracking. (F) NPY-hPLAP release was measured as described 
in Materials and methods using a double-stimulation protocol in control PC12 and cells expressing GFP–sh2-RNA or GFP–sh3-RNA. Released NPY-hPLAP 
is expressed as a percentage of total (n = 3 independent experiments). (G) Western blot using the anti–myosin VI antibody in wild-type (wt) or myosin VI 
stable knockdown (myosin VI KD) PC12 cells. A black line between the two lanes indicates the removal of intervening lanes from the original image for 
presentation purposes. (H) Wild-type or myosin VI knockdown PC12 cells expressing NPY-mCherry were imaged by TIRF microscopy for 40 min after a 
single high K+ stimulation. 40 frames per time point were analyzed, and the average SG density was quantified. SG density is expressed relative to the 
density values before stimulation. Error bars are means ± SEM. *, P < 0.05; **, P < 0.01; ***, P < 0.001.
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Changes in the type of movement undergone by SGs 
might also be expected in response to myosin VI over-
expression. We used TIRF microscopy to monitor the trajec-
tory of NPY-mCherry–positive SGs and calculate their MSD 
(Fig. 5, D–F). This analysis included SGs already in the TIRF 
plane as well as an SG moving toward the plasma membrane, 
with their trajectories being tracked for longer periods of 
time than in the previous analysis (Fig. 2 E and Fig. 4) using 
an automatic algorithm (see Materials and methods). In agree-
ment with the results obtained in myosin VI knockdown cells, 
overexpression of GFP-MyoVI-SIfull, but not GFP-MyoVI-
 NIfull, significantly reduced the MSD (Fig. 5, D and E) and the 
total displacement of the tracked SGs (Fig. 5 F). Indeed, in 
cells expressing GFP-MyoVI-SIfull, SG movement was re-
stricted to an area comparable to the known SG diameter 
(GFP-MyoVI-SIfull = 0.25 ± 0.04 µm2; Fig. 5 E). In contrast, 
in cells expressing GFP-MyoVI-SItail or GFP-MyoVI-NItail, 
SGs exhibited a significantly higher MSD than control cells or 
cells expressing the full-length proteins (Fig. 5, D and E; and 
Table 2), suggesting that by losing their anchoring points, the 
Figure 3. Myosin VI SI potentiates evoked 
exocytosis. (A) RT-PCR analysis of myosin VI 
isoform expression. -Actin primers were used 
as a control. (B) Cartoons of GFP-tagged myo-
sin VI constructs. The motor domain (purple) 
contains the actin- and ATP-binding sites, the 
reverse gear (761–814 aa, yellow) determines 
the unique directionality of myosin VI movement 
along actin, and the tail domain (orange) in 
the myosin VI SI (1,262 aa), but not the myo-
sin VI NI (1,253 aa), contains a 9-aa insert. 
GFP-MyoVI-tail constructs lack the motor do-
main and are unable to interact with F-actin. 
(C) GFP-MyoVI protein expression in PC12 
cells was evaluated by Western blotting using 
an anti–myosin VI antibody. Arrows indi-
cate GFP-MyoVI-full proteins (175 kD) and 
GFP-MyoVI-tail proteins (85 kD). (D) NPY-
hPLAP release was evaluated using a double- 
stimulation protocol in PC12 cells expressing 
GFP (control), GFP-MyoVI-SIfull, or GFP-MyoVI- 
NIfull. Released NPY-hPLAP is expressed as a 
percentage of total NPY-hPLAP (n = 3). (E) NPY- 
hPLAP release was measured in wild-type (wt) 
and myosin VI stable knockdown (KD) PC12 
cells overexpressing GFP (control), GFP-MyoVI-
SIfull (+GFP-MyoVI-SIfull), or GFP-MyoVI-NIfull 
(+GFP-MyoVI-NIfull). Released NPY-hPLAP is 
expressed as a percentage of wild-type PC12 
cells (n = 3). Error bars are means ± SEM. 
*, P < 0.05; **, P < 0.01; ***, P < 0.001.
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Figure 4. Myosin VI SI mediates the caging of SG to the cortical actin network in myosin VI knockdown cells. (A and B) Myosin VI stable knockdown (KD) 
PC12 cells coexpressing NPY-mCherry with GFP-MyoVI-SIfull (A) or GFP-MyoVI-NIfull (B) were imaged by TIRF microscopy before and after nicotine stimulation. 
Videos were acquired at a rate of one frame per second. The insets highlight the trajectories of GFP-MyoVI–positive (arrowheads) and GFP-MyoVI–negative 
(arrows) SGs during 12 s after stimulation. (C) Average MSD of NPY-mCherry–positive SGs tracked in untransfected myosin VI stable knockdown cells 
and in myosin VI stable knockdown cells expressing GFP-MyoVI-SIfull. (D) Average MSD of NPY-mCherry–positive SGs tracked in untransfected myosin VI 
stable knockdown cells and in myosin VI stable knockdown cells expressing GFP-MyoVI-NIfull. (E) Time-lapse series of a single NPY-mCherry–positive SG 
appearing in the TIRF plane and becoming highly restricted upon association with GFP-MyoVI-SIfull. The arrow points to the beginning of the trajectory of 
the SG. The arrowhead shows the end of this trajectory or the position of the SG at each time point. Video 1 shows the complete time series for this panel. 
(F) Time-lapse series of a single SG labeled with NPY-mCherry appearing in the TIRF plane and becoming GFP-MyoVI-NIfull positive with little effect on its 
movement. The arrow points to the beginning of the trajectory of the SG. The arrowhead shows the end of this trajectory or the position of the SG at each 
time point. Video 2 shows the complete time series for this panel. Bars: (A [main images], B [main images], E, and F) 5 µm; (A [insets] and B [insets]) 1 µm. 
Error bars are means ± SEM. ***, P < 0.001.
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Figure 5. Myosin VI SI regulates SG density and mobility in the cortical region. (A) TIRF images of NPY-mCherry (pseudocolored gray) coexpressed with 
GFP (control) or with the different GFP-MyoVI proteins in PC12 cells. Left insets show GFP or the respective GFP-MyoVI expression. The enlarged images on 
the right highlight a fixed area for comparison of SG density at the plasma membrane. (B and C) SG density (B) and SG speed (C) in the TIRF plane were 
quantified in the conditions described in A before and after 100 µM nicotine stimulation. (D and E) MSD versus time (D) and average values (E) after 40 s 
of tracking of NPY-mCherry–positive SGs shown in A. (F) PC12 cells coexpressing NPY-mCherry with GFP (control), GFP-MyoVI-SIfull, or GFP-MyoVI-SItail 
were imaged by TIRF microscopy. NPY-mCherry–positive SGs were tracked, and their lateral movement and displacement length were analyzed. Track 
displacement length is displayed as a color code. Note the high proportion of short trajectories when the GFP-MyoVI-SIfull was expressed and the very 
long tracks were detected upon expression of GFP-MyoVI-SItail. Bars: (A [main images and left insets] and F) 5 µm; (A [right insets]) 1 µm. Error bars are 
means ± SEM. **, P < 0.01; ***, P < 0.001.
309Myosin VI function in neuroexocytosis • Tomatis et al.
Although multiple and smaller GFP-positive structures were 
observed upon expression of GFP-MyoVI-SItail or GFP-MyoVI-
NItail, these did not colocalize with either Synaptotagmin-I 
or lifeact-mRFP (Fig. S4, B and D). Using correlative EM, 
we observed that fluorescent GFP-MyoVI-SIfull structures ex-
hibited a clear concentration of dense-core SGs (Fig. 6 A). 
The formation of GFP-MyoVI–positive structures and the clus-
tering of SGs around them were completely disrupted by la-
trunculin A inhibition of actin polymerization (Fig. S4, E–G; 
Spector et al., 1983). Importantly, GFP-MyoVI full-length 
expression did not affect microtubule organization (Fig. S4 H), 
and microtubule depolymerization by nocodazole (Jordan and 
Wilson, 1998) had no effect on the localization of GFP-MyoVI 
or the clustering of SG around the GFP-MyoVI–positive struc-
tures (Fig. S4, I and J).
We next evaluated whether nicotine stimulation could 
promote the recruitment of NPY-mCherry–positive SGs to the 
GFP-MyoVI–positive structures. Time-lapse confocal micros-
copy revealed a significant increase in NPY-mCherry intensity 
around the GFP-MyoVI-SIfull–positive structures, but not GFP-
MyoVI-NIfull structures, in response to stimulation (Fig. 6, 
B and C). This increase was not observed in cells coexpressing 
NPY-mCherry with either GFP-MyoVI-SItail or GFP-MyoVI-
NItail, indicating that the recruitment of SGs requires the inter-
action between myosin VI SI and F-actin (Fig. 6, D and E). 
Thus, the myosin VI SI isoform has the unique ability to recruit 
SGs in an F-actin– and activity-dependent manner in PC12 cells. 
Interestingly, in myosin VI stable knockdown PC12 cells, the 
occurrence of these large GFP-MyoVI–positive large structures 
was greatly diminished upon reexpression of GFP-MyoVI-full 
(Fig. 6 F), with the appearance of small puncta with an average 
area of 0.20 ± 0.01 µm2 that colocalized with Synaptotagmin-I 
(Fig. 6 G). The formation of the large structures detected upon 
GFP-MyoVI-full protein expression in PC12 cells is therefore 
likely to be driven by elevated levels of myosin VI.
Phosphorylation of myosin VI SI regulates 
its function in neuroexocytosis
The SI (Fig. 7 A) contains a potential tyrosine phosphoryla-
tion site (Y1114) within a DYD motif (residues 1,113–1,115) not 
present in the NI isoform. Bioinformatic analysis revealed that 
this DYD motif is a consensus site for c-Src kinase phosphory-
lation (Schwartz and Gygi, 2005) of Y1114 (Fig. 7, B and C). 
Immunoprecipitation experiments were conducted in PC12 cells 
coexpressing GFP-MyoVI-SIfull or GFP-MyoVI-NIfull with 
a constitutively active mutant of c-Src kinase, c-SrcY527F-GFP 
(Fig. 7 D; McLachlan et al., 2007). Tyrosine phosphorylation 
of GFP-MyoVI, analyzed by Western blotting using an anti-
phosphotyrosine antibody, revealed that myosin VI SI is indeed 
preferentially phosphorylated by c-Src when compared with myo-
sin VI NI (Fig. 7, D and E). To determine whether myosin VI SI 
phosphorylation occurs on Y1114, we generated a DYD dele-
tion mutant of GFP-MyoVI-SIfull (GFP-MyoVI-SIfullDYD; 
Fig. 7 C). As predicted, GFP-MyoVI-SIfullDYD was not 
phosphorylated after coexpression with c-SrcY527F-GFP. GFP-
MyoVI-SIfull phosphorylation was also detected after coexpres-
sion of wild-type c-Src-mCherry, suggesting that it also occurs 
SGs become more mobile. The MSD plots that we obtained 
from TIRF analysis were nonlinear (Fig. 5 D) and fitted those 
generated by caged movement (Steyer and Almers, 1999). The 
best fit was obtained with a confined diffusion model, which 
assumes that individual SGs diffuse within a restricted region 
or cage (Saxton and Jacobson, 1997). This model allowed us 
to calculate the diffusion coefficient for SG movement and 
the size of the cage area within which the SGs were confined. 
Consistent with a myosin VI SI–selective model restricting 
SG movements, we found that the diffusion coefficient in cells 
expressing GFP-MyoVI-SIfull was lower than that in control 
cells or cells expressing GFP-MyoVI-NIfull and that the MSD 
was significantly reduced (Table 2).
Myosin VI SI–positive structures recruit 
SGs in an activity-dependent manner in 
PC12 cells
After expression of GFP-MyoVI-SIfull or GFP-MyoVI-NIfull 
(but not GFP-MyoVI-SItail or GFP-MyoVI-NItail) in PC12 
cells, large GFP-positive structures were observed (area = 4.05 ± 
0.25 µm2) in addition to the cytosolic fluorescence (Fig. S3 A). 
This staining pattern noticeably differed from the small punc-
tate and plasma membrane staining pattern reported in HeLa 
and other cells (Buss et al., 1998, 2001; Bond et al., 2011), sug-
gesting that neurosecretory cells have the ability to concentrate 
a fraction of myosin VI upon overexpression. When expressed 
in wild-type PC12 cells, the GFP-MyoVI-full–positive struc-
tures did not colocalize with any of the tested subcellular com-
partment markers (Fig. S3 B), and their presence did not affect 
endocytic or constitutive exocytic events such as transferrin 
uptake and VSV-G protein delivery to the plasma membrane 
(Fig. S3, B and C).
To investigate whether these myosin VI–positive struc-
tures have the ability to restrict endogenous SGs, PC12 cells 
expressing GFP-MyoVI-SIfull or GFP-MyoVI-NIfull were 
immunostained for Synaptotagmin-I (Fig. S4 A). In both cases, 
a clear colocalization was observed, suggesting that the GFP-
MyoVI–positive structures were capable of recruiting SGs. 
Although GFP-MyoVI-SIfull or GFP-MyoVI-NIfull expres-
sion did not affect the organization of the cortical actin network 
(Fig. S3 D), we also investigated whether the GFP-MyoVI–
positive structures were able to recruit F-actin. Coexpression of 
lifeact-mRFP, an F-actin marker (Riedl et al., 2008), with GFP-
MyoVI-SIfull or GFP-MyoVI-NIfull revealed that actin colocal-
ized with the GFP-MyoVI–positive structures (Fig. S4 C). 
Table 2. Myosin VI SI restricts SG mobility in PC12 cells
NPY-mCherry–positive 
PC12 cells coexpressing
D Cage area
 µm2/s µm2
Control (GFP) 0.014 ± 0.008 0.55 ± 0.02
GFP-MyoVI-SIfull 0.010 ± 0.001 0.20 ± 0.01
GFP-MyoVI-SItail 0.020 ± 0.001 0.81 ± 0.02
GFP-MyoVI-NIfull 0.014 ± 0.006 0.61 ± 0.03
GFP-MyoVI-NItail 0.022 ± 0.006 0.68 ± 0.02
D, diffusion coefficient. Values are expressed as means ± 95% confidence 
interval.
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Figure 6. Myosin VI SI recruits SGs in an activity- and F-actin–dependent manner. (A) Bright-field, epifluorescence, and EM images of PC12 cells 
expressing GFP-MyoVI-SIfull processed for correlative EM. Arrows indicate dense-core SGs clustered in the region of transfected cells where the GFP-
MyoVI-SIfull–positive structures are located (insets). (B and C) Live-cell confocal images of PC12 cells coexpressing NPY-mCherry with GFP-MyoVI-SIfull 
(B) or GFP-MyoVI-NIfull (C) before (control) and after 100 µM nicotine (nicotine) stimulation. The insets highlight the NPY-mCherry–positive SGs clustered 
around GFP-MyoVI–positive structures. The NPY-mCherry images are shown as pseudocolor images. A region of interest around a GFP-MyoVI–positive 
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role by acting as a diffusion barrier, allowing the recruitment 
and restriction of SGs to the actin cytoskeleton beneath the 
plasma membrane (Nakata and Hirokawa, 1992; Trifaró and 
Vitale, 1993; Steyer and Almers, 1999; Oheim and Stühmer, 2000; 
Toonen et al., 2006). However, upon stimulation, this barrier 
loosens in response to Ca2+-mediated activation of proteins such 
as scinderins (Rodriguez Del Castillo et al., 1990; Vitale et al., 
1991; Lejen et al., 2002). The cortical actin network then plays 
a more active role by providing de novo actin tracks for granule 
movement when actin polymerization is induced by Rho and a 
rise in phosphatidylinositol(4,5)bisphosphate levels (Gasman 
et al., 2004; Wen et al., 2011).
Although considerable effort has been devoted to under-
standing the molecular events underlying neuroexocytosis, the 
complex mechanisms that allow SG recruitment and retention 
at the level of the cortical actin network, and their subsequent 
transport to the plasma membrane, remain to be fully elucidated. 
To gain insight into these mechanisms and to identify cytosolic 
proteins that regulate the recruitment of SGs to F-actin in a Ca2+-
dependent manner, we used purified SGs to pull down proteins 
from purified cytosol in the presence of Ca2+ and identified them 
by MS. Among the pulled down proteins were those known to 
interact with SGs in a Ca2+-dependent manner, such as annexin-2 
(Sarafian et al., 1991; Chasserot-Golaz et al., 2005), proteins 
involved in endocytic and exocytic trafficking pathways, such 
as heat shock protein-70 kD (Rothman, 1989; Jiang et al., 2000), 
and cytoskeleton components, including tubulin, actin, and my-
osin VI. Myosin VI was of interest as it had previously been de-
scribed to have an anchoring function that allows the attachment 
of membrane compartments to the actin cytoskeleton (Self et al., 
1999; Buss and Kendrick-Jones, 2008). Although it was recently 
found to colocalize with an SG marker in PC12 cells, its role in 
regulated secretion remains a matter of debate (Majewski et al., 
2011). Here, we provide the first demonstration that myosin VI 
interacts with SGs in a Ca2+-dependent manner and drives the 
tethering and retention of SGs to F-actin in the cortical actin 
network. The regulation of the anchoring property of myosin VI 
by Src kinase phosphorylation highlights the importance of 
posttranslational modifications in controlling myosin VI activ-
ity and its functional link with signal transduction pathways.
Myosin VI regulates the activity-dependent 
tethering of SGs to the cortical actin 
network and controls exocytosis in  
PC12 cells
Myosin VI is the only myosin that moves toward the minus 
end of actin filaments (Wells et al., 1999) and, in association 
with specific binding partners, functions in endocytosis, cell 
under milder levels of c-Src activity (Fig. S5 A). In addition, 
confocal microscopy showed that these proteins were highly 
colocalized when expressed in PC12 cells (Fig. S5 B).
To assess the role of c-Src kinase in myosin VI SI activity-
dependent recruitment of SGs (Fig. 6 B), PC12 cells coexpressing 
GFP-MyoVI-SIfull and NPY-mCherry were treated with PP2, a 
selective inhibitor of the Src kinase family (Hanke et al., 1996; 
Bain et al., 2003) and then analyzed in real time before and after 
nicotine stimulation. SG recruitment was completely blocked by 
PP2 treatment (Fig. 8 A), whereas PP3, an inactive analogue of 
PP2, had no effect, suggesting that c-Src kinase phosphorylation 
of GFP-MyoVI-SIfull is required to mediate the SG recruitment 
observed after stimulation. In addition, we observed that SG re-
cruitment was also blocked when NPY-mCherry was coexpressed 
with the phosphorylation-null mutant GFP-MyoVI-SIfull-DYD 
(Fig. 8 B). To test the importance of myosin VI SI phosphoryla-
tion in its function as an anchor for SGs, we performed TIRF 
microscopy on PC12 cells expressing NPY-mCherry either with 
GFP (control) or GFP-MyoVI-SIfullDYD (Fig. 8, D and E). 
At similar levels of expression (Fig. 8 C), deleting the DYD 
motif from myosin VI SI abolished the spatial restriction of SGs 
in the cortical region observed after GFP-MyoVI-SIfull expres-
sion (Fig. 8, D and E; and Fig. 5, D and E), thereby demonstrat-
ing that phosphorylation of the DYD motif is directly responsible 
for the caging of SGs on the cortical actin network abutting the 
plasma membrane. Finally, to investigate the role of Y1114 phos-
phorylation in neuroexocytosis, we measured high K+-stimulated 
NPY release in wild-type PC12 cells coexpressing NPY-hPLAP 
with GFP-MyoVI-SIfull or GFP-MyoVI-SIfullDYD (Fig. 8 F). 
This revealed that in cells expressing GFP-MyoVI-SIfullDYD, 
NPY release was comparable to that observed in control cells 
expressing GFP in both the first and second rounds of stimulation 
(15 and 45 min), confirming that the potentiating effect observed 
upon GFP-MyoVI-SIfull expression was abolished by deleting 
the DYD motif (Fig. 8 F). A similar effect was seen when cells 
coexpressing NPY-hPLAP and GFP-MyoVI-SIfull were treated 
with PP2 (Fig. S5 C). More importantly, expression of GFP-
MyoVI-SIfullDYD failed to rescue evoked release when over-
expressed in myosin VI stable knockdown PC12 cells (Fig. 8 G). 
Together, these results demonstrate that phosphorylation of myo-
sin VI SI in the DYD motif by a Src kinase family member, prob-
ably c-Src kinase, is required to regulate myosin VI SI isoform 
function in regulated exocytosis.
Discussion
In neurosecretory cells, the cortical actin network has a key 
role in neuroexocytosis. In resting conditions, it plays a passive 
structure was used for quantification of NPY-mCherry fluorescence (right graphs) in the conditions described in B and C. (D and E) Quantification of NPY-
mCherry fluorescence around GFP-MyoVI-SItail (D)– or GFP-MyoVI-NItail (E)–positive structures before (control, black) and after 100 µM nicotine stimulation 
(nicotine, red). Average NPY-mCherry fluorescence is expressed as a percentage of initial fluorescence. (F) GFP-MyoVI-SIfull and GFP-MyoVI-NIfull were 
expressed in wild-type (wt) or myosin VI stable knockdown (myosin VI KD) PC12 cells. After fixation, cells were imaged by confocal microscopy, and the 
number of cells harboring large GFP-MyoVI–positive structures (large structures) or small punctate cytosolic distribution (small puncta) were counted and ex-
pressed as a percentage of the total number of transfected cells (n = 3 independent experiments). (G, left) Confocal images of myosin VI stable knockdown 
PC12 cells expressing GFP-MyoVI-SIfull or GFP-MyoVI-NIfull immunolabeled with Synaptotagmin-I (red). The enlarged images show the association between 
expressed GFP-MyoVI and Synaptotagmin-I (Syt-I). (right) Analysis of the colocalization between Synaptotagmin-I and the different GFP-MyoVI. Bars: (B, C, 
and G [main images]) 5 µm; (B, C, and G [insets]) 1 µm. Error bars are means ± SEM. **, P < 0.01; ***, P < 0.001.
 
JCB • VOLUME 200 • NUMBER 3 • 2013 312
Figure 7. Myosin VI SI isoform is phosphorylated by c-Src kinase. (A) Alignment of the tail domain sequences of the myosin VI SI and myosin VI NI 
isoforms. The DYD motif comprises part of the SI (9 aa) and an adjacent aspartate (D1113) and tyrosine (Y1114) residue (red, aa 1,113–1,123). 
(B, top) Prediction of tyrosine phosphorylation sites in the region 1,100–1,150 aa in the myosin VI SI (left) and myosin VI NI (right) isoforms. Highlighted 
in red is the Y1114 residue that displays a higher phosphorylation score in myosin VI SI than in myosin VI NI (0.912 vs. 0.726). (bottom) Prediction 
of kinase-specific phosphorylation sites in myosin VI SI (left) and myosin VI NI (right) isoforms. Highlighted in red is the Y1114 residue predicted to be 
phosphorylated by c-Src protein kinase in myosin VI SI. (C) Schematic comparison between GFP-MyoVI-SIfull and GFP-MyoVI-SIfullDYD (see Fig. 3  
for colored references) with the deleted DYD motif (aa 1,113–1,115) in red. (D) Immunoprecipitation of GFP-MyoVI from cells coexpressing GFP-MyoVI-
SIfull, GFP-MyoVI-NIfull, or GFP-MyoVI-SIfullDYD with c-SrcY527F-GFP. (top) Western blotting using an anti–myosin VI antibody. Arrows indicate 
GFP-MyoVI. (middle) Phosphorylation of immunoprecipitated GFP-MyoVI detected by Western blotting using antiphosphotyrosine (pY) antibody. (bot-
tom) c-SrcY527F-GFP expression detected by Western blotting using a specific antiphospho-Src antibody (pY416-Src, 84 kD). (E) Quantification of 
phosphorylated GFP-MyoVI expressed as a percentage of phosphorylated GFP-MyoVI-SIfull (n = 3). IP, immunoprecipitation; WB, Western blot. Error 
bars are means ± SEM. **, P < 0.01; ***, P < 0.001.
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migration, and constitutive protein secretion (Buss et al., 2001; 
Aschenbrenner et al., 2003; Roberts et al., 2004; Au et al., 
2007; Bond et al., 2011). Here, we demonstrate that in neu-
rosecretory cells, myosin VI has a novel role in actively re-
cruiting SGs to the cortical actin network. When myosin VI 
expression is knocked down, the pool of SGs retained close 
to the cell surface is reduced. Although the average speed 
of the SGs is not affected in this condition, the pool of SGs 
progressing toward the plasma membrane displays a less re-
stricted movement, suggesting the loss of an anchoring point 
to the cortical region mediated by myosin VI. Importantly, 
the sustainability of SG exocytosis is impaired after myosin VI 
knockdown. Our results indicate that myosin VI does not 
affect the early stages of stimulated secretion, but by maintain-
ing an active pool of SGs below the plasma membrane and 
actively recruiting them to the cortical actin network, it plays 
a critical role in sustaining neuroexocytosis. Further evidence 
that the interaction between myosin VI and F-actin is required 
for the cortical tethering and retention of SGs was provided 
by the observation that expression of myosin VI tail, a truncated 
protein that is unable to interact with F-actin, dramatically 
reduced the pool of SGs near the plasma membrane and in-
creased the average speed of the SGs.
Myosin Va has also been implicated in neurosecretion. It 
is present on SGs (Lejen et al., 2002; Varadi et al., 2005) and 
is involved in SG movement to the cell surface (Prekeris and 
Terrian, 1997; Rudolf et al., 2003; Eichler et al., 2006; Desnos 
et al., 2007; Kögel et al., 2010). Therefore, myosin Va and 
VI may have synergistic roles, with myosin VI acting in the 
recruitment and retention of SGs to the cortical actin network 
and myosin Va involved in the active transport of SGs toward 
the plasma membrane. Interestingly, a recent in vitro study using 
single myosin Va and myosin VI molecules linked to the same 
cargo describes how physical communication between these mo-
lecular motors could modulate cargo delivery (Ali et al., 2011).
Myosin VI SI isoform controls the 
recruitment of SGs to F-actin and 
regulated exocytosis in PC12 cells
Although large insert and NI isoforms of myosin VI have been 
reported to be involved in cargo sorting and clathrin-mediated 
endocytosis (Au et al., 2007; Puri, 2009), the function of the 
SI isoform was unknown. We confirmed that PC12 cells en-
dogenously express both the myosin VI SI and myosin VI NI 
isoforms (Majewski et al., 2010). Although the expression of 
truncated tail mutants of both isoforms affected SG speed and 
mobility near the plasma membrane, only the myosin VI SI 
tail mutant reduced SG density, suggesting that the tethering 
and retention of SGs to the cortical region is predominantly 
mediated by the myosin VI SI isoform. We also observed that 
additional SGs were recruited in an activity-dependent man-
ner around myosin VI SI–positive structures alone and that 
although expression of this isoform did not affect the net den-
sity of SG near the plasma membrane, it did potentiate their 
evoked release. Consistent with a specific role of the myo-
sin VI SI in neuroexocytosis, we found that this isoform, but 
not myosin VI NI, was able to restore the defective exocytic 
phenotype detected in myosin VI knockdown cells by mediat-
ing the efficient caging and retention of SGs in the cortical 
actin network. Thus, our data provide the first demonstration 
that the myosin VI SI isoform acts as an anchor molecule and 
is responsible for the activity-dependent recruitment of SGs 
to F-actin in PC12 cells, a function that is required for the 
maintenance of an active and competent pool of SGs needed 
to sustain neuroexocytosis.
Phosphorylation as a positive regulatory 
mechanism for the role of myosin VI SI  
in neuroexocytosis
The activity of several kinases is known to modulate neurotrans-
mitter release pre- and postsynaptically (Gurd, 1997; Turner et al., 
1999). c-Src kinase is highly expressed in neurosecretory cells 
and neurons and is associated with synaptic vesicles (Onofri et al., 
1997; Ingley, 2008). Although c-Src kinase activity is up-regulated 
by Ca2+, its functions in regulated exocytosis remain a matter of 
debate (Pang et al., 1988; Linstedt et al., 1992; Rusanescu et al., 
1995). In neuronal cells, c-Src has been variously reported to 
have an inhibitory effect mediated by its substrate synapsin-1 
(Messa et al., 2010) as well as a stimulatory role in promoting 
glutamate release (Wang, 2003; Shyu et al., 2005). In PC12 cells, 
treatment with 20 µm PP2 increased catecholamine release after 
high K+ stimulation, an action attributed to a general disturbance 
of the actin cytoskeleton, again suggesting an inhibitory role 
(Ohnishi et al., 2001). Here, we demonstrate that phosphoryla-
tion of myosin VI SI on a predicted c-Src kinase consensus site is 
necessary for the function of myosin VI SI in sustaining SG fu-
sion, pointing to a positive role for c-Src kinase in neuroexocyto-
sis. Although this effect was also observed when the Src kinase 
inhibitor PP2 was used, PP2 alone did not affect release in PC12 
cells during the first 15 min of stimulation, as would be expected. 
Although the reason for this is currently unknown, it could reflect 
competing known functions of c-Src kinase in the initial stages 
of neuroexocytosis. However, possible confounding effects of 
PP2 on other kinases cannot be ruled out at this time. Future stud-
ies directly targeting identification of the signaling pathway reg-
ulating myosin VI SI function will be needed to fully address this 
aspect of neurosecretion. In summary, our work describes a novel 
role for the myosin VI SI isoform in the regulation of the activity-
dependent tethering of SGs to the cortical actin network in neu-
rosecretory cells, a key process that is potentially regulated by 
c-Src kinase phosphorylation.
Materials and methods
Plasmids
The GFP-MyoVI plasmids (GFP-MyoVI-SIfull, GFP-MyoVI-SItail, GFP-MyoVI-
NIfull, and GFP-MyoVI-NItail) have been described previously (Buss et al., 
2001; Au et al., 2007). In brief, the human full-length myosin VI cDNA 
of the different myosin VI isoforms (UniProt accession no. Q9UM54-2 
[SI, 1–1,262 aa] and Q9UM54-5 [NI, 1–1,253 aa]) or the restriction frag-
ments covering their predicted tail domains (840–1,262 or 1,253 aa) 
were cloned into the mammalian expression vector pEGFP-C3 (Takara Bio 
Inc.) so that they were expressed at the C terminus of EGFP (Fig. 3 B). 
Lifeact-mRFPruby (Lifeact-mRFP) was provided by R. Wedlich-Soldner (Max 
Planck Institute of Biochemistry, Martinsried, Germany; Riedl et al., 2008), 
pCMV-NPY-hPLAP was provided by S. Sugita (University of Toronto and 
University Health Network, Toronto, Ontario, Canada), c-Src-mCherry and 
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Figure 8. The function of myosin VI SI in neuroexocytosis is regulated by c-Src kinase phosphorylation. (A, left) PC12 cells coexpressing GFP-MyoVI-SIfull 
and NPY-mCherry pretreated with DMSO, PP3, or PP2 for 40 min at 37°C and imaged after 100 µM nicotine stimulation in the presence of DMSO (nicotine + 
DMSO), PP3 (nicotine + PP3), or PP2 (nicotine + PP2). (right) Quantification of NPY-mCherry fluorescence around GFP-MyoVI–positive structures in the conditions 
shown in the left images. The NPY-mCherry images are shown as pseudocolor images. (B, left) PC12 cells coexpressing NPY-mCherry with GFP-MyoVI-SIfull 
or GFP-MyoVI-SIfullDYD after 100 µM nicotine (nicotine) stimulation. (right) Quantification of NPY-mCherry fluorescence around GFP-MyoVI–positive structures 
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c-SrcY527F-GFP were provided by A. Yap (Institute for Molecular Biosci-
ence, University of Queensland, Queensland, Australia; McLachlan and 
Yap, 2011), and VSV-G was provided by J.L. Daniotti (Universidad Nacio-
nal de Córdoba, Ciudad Universitaria, X5000 HUA Córdoba, Argentina; 
Keller et al., 2001). pEGFP-C3 was obtained from Takara Bio Inc. The GFP-
MyoVI-SIfull DYD motif deletion (1,113–1,115 aa) was generated by site-
directed mutagenesis using the site-directed mutagenesis kit (QuikChange 
Lightning; Agilent Technologies) and mutational primers 5-CCAAAGTCT-
GTTACTTTTGCACCATTTTTG-3 and 5-CAAAAATGGTGCAAAAGTAA-
CAGACTTTGG-3. pCMV-NPY-mCherry (NPY-mCherry) was generated from 
pCMV-NPY-emerald GFP provided by S. Sugita. In brief, mCherry was 
amplified from pmCherry-C1 (Takara Bio Inc.) by PCR using the following 
primers: forward, 5-ATCGATAAGCTCATGGTGGCAAGGGCGAG-3; 
and reverse, 5-CAAGTAAAACCTCTACAAATGTGGTATGGC-3. Then, 
it was subcloned into pCMV-NPY-emerald GFP using ClaI and BamHI, 
replacing emerald GFP. All constructs were sequenced in the Australian 
Genome Research Facility at the University of Queensland.
Cell culture and DNA transfection
PC12 cells were maintained at 37°C, 5% CO2 in DMEM supplemented with 
5% Serum Supreme (Lonza), 5% heat-inactivated horse serum (Gibco; Invitro-
gen), and 0.5% GlutaMAX (Gibco; Invitrogen). Cells were transfected 
with a 1–2.5-µg/35-mm dish of the indicated plasmid using the reagent 
(Lipofectamine LTX; Invitrogen) according to the manufacturer’s instruc-
tions. After 24 h, transfected cells were replated onto poly-d-lysine–coated 
glass-bottomed culture dishes (MatTek Corporation) or coverslips and then 
processed for live-cell imaging or immunocytochemistry experiments 72 h 
after transfection.
Antibodies
Mouse anti-Synaptobrevin/VAMP2 (1:400), mouse anti–Synaptotagmin-1 
clone 41.1 (1:500–1,000), and mouse anti-SNAP25 (1:1,000) were ob-
tained from Synaptic Systems, mouse anti-EEA1 (1:400) and mouse anti-
GM130 (1:1,000) were obtained from BD, monoclonal rabbit anti-Rab5 
(1:500) and rabbit antiphosphotyrosine 416 Src (pY416-Src; 1:500) were 
purchased from Cell Signaling Technology, mouse anti–-actin clone AC-74 
(1:20,000) was purchased from Sigma-Aldrich, and mouse antiphospho-
tyrosine clone 4G10 (1:500) was obtained from EMD Millipore. Rabbit 
anti–Syntaxin-6 (1:800) was a gift from D. James (Garvan Institute, Sydney, 
Australia), mouse anti–protein disulfide isomerase (1:600) was a gift 
from J. Stow (Institute for Molecular Bioscience, University of Queensland, 
Queensland, Australia), and rabbit anti–myosin VI antibody (1:500; 
Fig. 1 C) was provided by A. Yap. For immunocytochemistry, protein ex-
pression analyses, and immunoprecipitation experiments, a rabbit poly-
clonal anti–myosin VI antibody raised against aa 920–1,034, located in 
the tail domain of this protein (Buss et al., 1998), was used (1:1,000). 
1 µg rabbit IgG (Sigma-Aldrich) was used as a control for immunoprecipi-
tation experiments. The secondary antibodies goat anti–mouse Alexa Fluor 
546 and goat anti–rabbit Alexa Fluor 488 (1:400; Molecular Probes; 
Invitrogen) were used for immunocytochemistry. Anti–mouse (IRDye 680 
or 800) and anti–rabbit (IRDye 680 or 800) infrared antibodies were 
used for Western blotting (1:25,000; LI-COR Biosciences).
Protein electrophoresis and Western blotting
Cells were harvested by scraping, homogenized, and analyzed by SDS-
PAGE followed by Western blotting using the indicated antibodies. Quan-
tification was performed using ImageJ software (National Institutes of 
Health). The mean intensity of each individual band of interest was calcu-
lated after background value subtraction. Values were normalized to the 
mean intensity of the loading control band for each sample. To quantify 
phosphorylated GFP-MyoVI, the mean intensity of the phospho–GFP-MyoVI 
band was normalized to the total immunoprecipitated GFP-MyoVI.
SGs and cytosol purification from bovine adrenal medulla
Bovine adrenal medullas were fractionated as previously described (Simon 
et al., 1988; Meunier et al., 2005; Wen et al., 2011). In brief, isolated 
medullas were homogenized in 0.32 M sucrose in 10 mM Tris and 1 mM 
EGTA, pH 7.4, and centrifuged 2 × 15 min at 800 gav. The supernatant 
was centrifuged again for 20 min at 12,000 gav, and the pellet (12,000 
pellet) was resuspended in 0.32 M sucrose in 10 mM Tris and 1 mM 
EGTA, pH 7.4, and loaded on a linear sucrose gradient (34–68%). After 
a 1-h centrifugation at 100,000 gav, 12 × 1–ml fractions were collected 
from the top of the gradient. To assess SG purification, 50 µg of each 
fraction was analyzed by SDS-PAGE and Western blotting against mark-
ers of different subcellular compartments (Vitale et al., 1996). The super-
natant from the 12,000 gav spin (12KSN) was further centrifuged for 1 h 
at 100,000 gav, and the resulting supernatant was collected (100KSN). 
For the cytosol preparation, the 100KSN fraction was dialyzed overnight 
at 4°C in potassium glutamate buffer (KGEP buffer; 139 mM potassium 
glutamate, 5 mM glucose, 5 mM EGTA, and 20 mM Pipes-NaOH, pH 6.8) 
containing 2 mM of free MgCl2, 2 mM ATP, and 0 or 100 µM of free 
Ca2+, calculated using the WEBMAXC program (Patton et al., 2004).
Ca2+-dependent recruitment of myosin VI to SGs
100 µg of purified SGs was incubated with 1 mg cytosol for 30 min at 
37°C in KGEP buffer containing 2 mM of free MgCl2, 2 mM ATP, and the 
indicated free Ca2+ concentrations. Reactions were stopped by adding 
750 µl of ice-cold KGEP buffer containing the respective [Ca2+], and SGs 
were isolated by ultracentrifugation for 45 min at 50,000 rpm at 4°C. SG 
pellets were washed once with 250 µl of ice-cold KGEP buffer containing 
Ca2+ and then further ultracentrifuged for 45 min at 50,000 rpm at 4°C. 
Pellets were resuspended in Laemmli sample buffer plus -mercaptoethanol, 
mixed for 10 min, and processed for SDS-PAGE and Western blotting.
Pull-down of cytosolic proteins using SGs as bait and protein identification 
by MALDI-TOF/TOF-MS/MS
Sample preparation. Chromaffin granules (2 mg) were dissolved in 100 µl 
of 2% wt/vol SDS (Sigma-Aldrich) at 55°C for 1 h. Proteins were precipi-
tated overnight with 1 ml of 100% methanol at 20°C and then pelleted 
at 16,000 g for 30 min at 4°C in a refrigerated microfuge (5415 R; 
Eppendorf). Pellets were washed carefully with 1 ml of 20°C methanol 
and allowed to air dry.
For analysis without protein normalization, pellets were reduced 
in 100 µl of 2% wt/vol SDS, 50% vol/vol trifluoroethanol (TFE; Sigma- 
Aldrich), 0.1 M ammonium bicarbonate (Sigma-Aldrich), pH 8, and 10 mM 
DTT (Sigma-Aldrich) at 65°C for 1 h. Samples were alkylated by the ad-
dition of freshly prepared 0.5 M iodoacetamide (Sigma-Aldrich) to a final 
concentration of 50 mM and incubated in the dark at 55°C for 1 h.
Protein normalization was performed using an extensive modifica-
tion of ProteoMiner (BioRad Laboratories). Protein pellets were resuspended 
in 50 µl of 50% vol/vol TFE at 65°C for 1 h, after which 50 µl PBS was 
added to dilute the TFE concentration to 25% vol/vol. 40 µl ProteoMiner 
resin slurry (20 µl of actual resin) was washed twice by vortexing with 1 ml 
of water for 30 s, with a brief spin in a capsule microfuge to pellet the 
resin. The resin was equilibrated by twice vortexing as described with PBS, 
after which 100 µl of sample in 25% vol/vol TFE was added to the 20 µl 
of washed resin and incubated at 22°C for 90 min at the lowest speed in 
a benchtop vortex to keep the resin in suspension. The resin was then briefly 
pelleted in a capsule microfuge and washed twice with PBS and twice with 
water. Proteins were simultaneously eluted and reduced from the resin in 
100 µl of 2% wt/vol SDS, 50% vol/vol TFE, 0.1 M ammonium bicarbon-
ate, and 10 mM DTT at 65°C for 1 h. The resin was then pelleted, and the 
supernatant was transferred to a fresh tube, alkylated as by the addition of 
fresh 0.5 M iodoacetamide to a final concentration of 50 mM, and incu-
bated in the dark at 55°C for 1 h.
under conditions described on the left. (C) GFP-MyoVI-SIfull and GFP-MyoVI-SIfullDYD expression in PC12 cells were evaluated by Western blotting using 
the anti–myosin VI antibody. The arrow indicates the GFP-MyoVI proteins (175 kD). (D) PC12 cells coexpressing NPY-mCherry with GFP (control), GFP-
MyoVI-SIfull, or GFP-MyoVI-SIfullDYD were imaged by TIRF microscopy. NPY-mCherry–positive SGs were tracked after stimulation, and the average MSD 
during the first 40 s was plotted. (E) Average MSD at 40 s of tracking of NPY-mCherry–positive SGs. The results for control and GFP-MyoVI-SIfull–expressing 
cells are the same as those shown in Fig. 5 (D and E). (F) NPY-hPLAP release was evaluated using a double-stimulation protocol in PC12 cells expressing 
GFP (control), GFP-MyoVI-SIfull, or GFP-MyoVI-SIfullDYD. Released NPY-hPLAP is expressed as a percentage of total NPY-hPLAP (n = 3). The results for 
control and GFP-MyoVI-SIfull–expressing cells are the same as those shown in Fig. 3 D. (G) NPY-hPLAP release was measured in wild-type (wt) PC12 cells 
and myosin VI stable knockdown (KD) PC12 cells expressing GFP (control) or GFP-MyoVI-SIfullDYD (+GFP-MyoVI-SIfullDYD). Released NPY-hPLAP is 
expressed as a percentage of rescue compared with wild-type PC12 cells (n = 3). Bars: (A and B, left) 5 µm; (A and B, right) 1 µm. Error bars are means ± 
SEM. *, P < 0.05; **, P < 0.01; ***, P < 0.001.
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to have a 95% significant difference in abundance between +Ca and 
Ca samples. Data were combined into a CSV file for further analysis in 
a spreadsheet.
GFP-MyoVI immunoprecipitation
After 72 h of transfection with the indicated plasmids, PC12 cells were 
treated with 0.1 mM pervanadate in physiological saline solution (PSS) 
control buffer (145 mM NaCl, 5.6 mM KCl, 0.5 mM MgCl2, 5.6 mM glu-
cose, and 15 mM Hepes-NaOH, pH 7.4) during 10 min at 37°C (Radha 
et al., 2004; McLachlan and Yap, 2011). To allow cell entry, sodium or-
thovanadate (vanadate) was combined with hydrogen peroxide to form 
peroxyvanadate (pervanadate). After treatment, cells were homogenized 
in ice-cold TNE buffer (5 mM Tris, pH 7.5, 140 mM NaCl, and 5 mM 
EDTA) containing complete protease and phosphatase inhibitor cocktails 
(Roche). Lysates were centrifuged for 5 min at 3,000 rpm at 4°C, and pro-
tein concentration was determined. 500 µg protein was solubilized in ra-
dioimmunoprecipitation assay buffer (50 mM Tris-HCl, pH 8, 150 mM NaCl, 
1% NP-40, 0.5% deoxycholate, and 0.1% SDS) containing protease and 
phosphatase inhibitors by mixing at 4°C for 30 min. After 5 min centrifuga-
tion at 15,000 rpm at 4°C, supernatants were incubated for 30 min with 
protein A/G agarose beads (Thermo Fisher Scientific) at 4°C to eliminate 
nonspecific binding. Samples were then centrifuged for 4 min at 15,000 rpm 
at 4°C, after which the supernatants were incubated for 2 h at 4°C with the 
respective antibodies. Beads were added to the samples and further incu-
bated for 1 h at 4°C. Samples were then centrifuged for 2 min at 4°C at 
15,000 rpm, and supernatants were kept for further analysis. The beads 
were washed in radioimmunoprecipitation assay buffer, resuspended in 
Laemmli sample buffer containing -mercaptoethanol, and processed for 
SDS-PAGE and Western blotting.
Myosin VI knockdown
For transient myosin VI knockdown, PC12 cells were transfected twice at 
24-h intervals using Lipofectamine LTX (Invitrogen) and shRNA constructs 
against rat myosin VI (XM_236444; obtained from the NCBI Nucleotide 
database) target sequences: clone 2 (sh2-RNA), 5-AGATGACCTTC-
GAGTCAGTTT-3; clone 3 (sh3-RNA), 5-AAGCGACTCGATAAGTTCAAT-3; 
and scrambled RNA (control), 5-GGAATCTCATTCGATGCATAC-3 
(SABiosciences). Each shRNA vector expressed GFP under a separate pro-
moter. To generate stable myosin VI knockdown PC12 cells, puromycin- 
resistant sh2-RNA (SABiosciences) was used. Transfected cells were selected 
using 3 µg/ml puromycin for 3 wk and subsequently maintained in 2.5 µg/ml 
puromycin. For TIRF experiments, PC12 cells were transfected twice at 
24-h intervals, with NPY-mCherry and control, sh2-RNA, or sh3-RNA plas-
mids as in this paragraph, and the cells were sorted using a cell sorter (Influx; 
BD). Sorted cells were analyzed by SDS-PAGE and Western blotting for 
myosin VI levels or plated on glass-bottomed culture dishes for imaging. For 
the NPY-hPLAP release assay, PC12 cells were cotransfected twice at 24-h 
intervals with NPY-hPLAP and control, sh2-RNA, or sh3-RNA plasmids as in 
this paragraph. 48 h after the last transfection, myosin VI levels were deter-
mined by Western blotting, and NPY-hPLAP release assays were performed.
Analysis of myosin VI splice variants by RT-PCR
Total RNA was extracted from PC12 cells and rat liver using RNeasy mini 
kit (QIAGEN). Poly(A)+ RNA was reverse transcribed, and PCR products 
were produced using the RT-PCR kit (ProtoScript M-MuLV Taq; New Eng-
land Biolabs, Inc.). To amplify the regions of the myosin VI tail domain con-
taining both the large inserts and SIs, the following primers were used: 
forward, 5-GGAAGAGGAGTCCCAGCAG-3; and reverse, 5-CTGAGGG-
TCTTTGTACTGGT-3. To amplify -actin, the following primers were 
used: forward, 5-TCACCCACACTGTGCCCATCTATGA-3; and reverse, 
5-TCAGGAGGAGCAATGATCTTGA-3.
NPY-hPLAP release assay
Wild-type PC12 cells or myosin VI stable knockdown cells were transfected 
with NPY-hPLAP plasmid and the indicated constructs for 72 h. Cells were 
washed and incubated with PSS buffer as a control (145 mM NaCl, 5.6 mM 
KCl, 0.5 mM MgCl2, 5.6 mM glucose, and 15 mM Hepes-NaOH, pH 7.4) 
or stimulated with high K+-PSS buffer (81 mM NaCl, 70 mM KCl, 2.2 mM 
CaCl2, 0.5 mM MgCl2, 5.6 mM glucose, and 15 mM Hepes-NaOH, 
pH 7.4) for 15 min (first round of stimulation) at 37°C. After this initial stim-
ulation, the supernatants were collected, and the cells were washed and rein-
cubated with PSS or high K+-PSS buffer for 45 min at 37°C (second round 
of stimulation). For time course experiments using a single high K+ treat-
ment (60 min) or double protocol of stimulation (as described in the previ-
ous paragraph), supernatants were collected every 5 or 10 min after the 
first simulation during the course of the experiment. After collecting the 
Trypsin digestion. Trypsin coprecipitation was performed by carefully 
adding 2 µl of 1-mg/ml trypsin (Roche; modified sequencing grade in 5 mM 
HCl) to the side of the tube containing the reduced and alkylated proteins, 
washing the droplet into the sample using 1 ml of 20°C methanol, and 
allowing the sample and trypsin to coprecipitate overnight at 20°C be-
fore pelleting and air drying. Trypsin digestion was performed by resus-
pending the pellet in 50 µl of 0.1-M ammonium bicarbonate, pH 8, and 
incubating for 2 h at 37°C. An additional 2 µl of 1-mg/ml trypsin was 
added, and the sample was incubated for 4 min at the lowest power set-
ting (90 W) in an inverter microwave to complete the digestion. Digestion 
was halted by the addition of 5 µl of 5% vol/vol aqueous trifluoroacetic 
acid (TFA; Fluka).
HPLC. Samples were filtered through a 0.45-µm centrifugal filter 
(Nanosep; Pall Corporation) at 16,000 g for 2 min. HPLC was performed 
using an HPLC (UltiMate 3000; Dionex) with a 1:100 flow splitter for capil-
lary HPLC flow rates. 5 µl of the filtered sample was injected onto a 200-µm × 
50-mm monolithic polystyrene-divinylbenzene column (PepSwift; LC Pack-
ings) with an inline 200-µm × 5-mm monolithic trap column (LC Packings). 
The aqueous phase was 0.05% TFA in water. The mobile phase (B) was 
0.045% TFA in 80:20 acetonitrile/water. Separation was performed at 
65°C at a flow rate of 2.5 µl/min. Gradient conditions were as follows: 
0–10 min at 0% B; 50 min at 25% B; 80 min at 60% B; 90–96 min at 
100% B; and 98–120 min at 0% B.
Matrix-assisted laser desorption ionization (MALDI) MS. HPLC eluates 
were automatically spotted onto polished steel MALDI targets (MTP 384; 
Bruker) at 15-s intervals using a MALDI spotting robot (Proteineer SP; 
Bruker). The sample was spotted 1:2 with diluted -cyano-4-hydroxycin-
namic acid (CHCA; Bruker). The diluted matrix was prepared by 1:10 di-
lution of saturated CHCA in acetone (Sigma-Aldrich) into 6:3:1 ethanol 
(Sigma-Aldrich)/acetone/0.1% TFA. The peptide calibration mixture (Bruker) 
was manually spotted onto the appropriate calibration positions. Targets 
were allowed to air dry for 30 min before loading into the ion source of 
the MALDI–time of flight (TOF)/TOF (Ultraflex III; Bruker). Automated data 
acquisition was performed using the Compass 1.3 suite of the software 
(FlexControl, FlexAnalysis, WarpLC, and BioTools; Bruker). MALDI-TOF-MS 
was performed in positive ion reflector mode with digitizing at 1 GHz to 
allow acquisition with a laser rate of 200 Hz over the mass/charge (m/z) 
range of 900–3,500. For each spot, 200 laser shots (10 × 20 shots at 
random positions) were acquired at fixed laser intensity, with no fuzzy 
logic used for either laser intensity or data summation. Close external calibra-
tion was automatically performed using MH+ ions of angiotensin II (m/z = 
1,046.54), angiotensin I (m/z = 1,296.68), substance P (m/z = 1,347.74), 
bombesin (m/z = 1,619.82), adrenocorticotropic hormone 1–17 (m/z = 
2,093.09), adrenocorticotropic hormone 18–39 (m/z = 2,465.20), and 
somatostatin 28 (m/z = 3,147.47). MALDI-TOF/TOF-MS/MS (LIFT) was 
performed on parent ions selected by WarpLC. 200 laser shots were ac-
quired in parent ion mode for which the laser power was increased by 
70%, and a further 800 shots were acquired in fragment ion mode. No 
fuzzy logic was used during the MS/MS acquisition. All LIFT was acquired 
at 200 Hz using a 1-GHz digitizer rate.
Data processing. Each sample was separated twice by HPLC, and 
each target was analyzed twice by MALDI-TOF/TOF (LC-MALDI) for a total 
of four LC-MALDI datasets per sample. The four BTDX.xml files generated 
by WarpLC and BioTools, containing parent and fragment ion mass and 
intensity data for each run, were combined using an in-house algorithm to 
generate an averaged Mascot (Matrix Science) generic file (MGF) repre-
sentative of the total peptides present in all four runs. The Mascot generic 
files of averaged data were used to perform an in-house Mascot search of 
the International Protein Index bovine database and SwissProt database 
(all taxa) using the following parameters: enzyme containing semitrypsin 
with two missed cleavages, fixed modifications of carbamidomethylcyste-
ine, variable modifications of deamidated NQ and oxidized M, peptide 
tolerance of 50 ppm, and MS/MS tolerance of 0.5 D. Mascot output was 
saved as a comma separated variable (CSV) file. Semiquantitative com-
parative analysis of calcium-treated (+Ca) and untreated (Ca) data was 
performed using an in-house algorithm. In brief, the protein ID and Mascot 
score present in the CSV data from the +Ca and Ca database searches 
were compared and separated into three classes: proteins uniquely identi-
fied in the +Ca search, proteins uniquely identified in the Ca search, and 
“common” proteins identified in both searches. For each common protein, 
the log2 ratio (Mascot ratio) of its Mascot score from +Ca and Ca was 
calculated. Individual Mascot ratios from all common proteins were then 
used to calculate a mean Mascot ratio and standard deviation. For each 
protein Mascot ratio, the number of standard deviations () from the mean 
ratio was calculated. Proteins with a  >2 or less than 2 were considered 
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Transferrin uptake. Cells expressing GFP-MyoVI proteins were incu-
bated with transferrin-647 (1:500; Molecular Probes; Invitrogen) for 1 h 
at 37°C in serum-free DMEM. After washing in PBS, cells were fixed in 4% 
PFA/PBS, briefly rinsed in H2O, and mounted using ProLong Gold for con-
focal imaging.
TIRF microscopy
After transfection, cells were visualized with a TIRF microscope (Marianas 
and Everest; Intelligent Imaging Innovations, Inc.) fitted with a 100× oil 
immersion objective (NA 1.46; Carl Zeiss) using an electron multiplying 
charge-coupled device camera (QuantEM 512SC; Photometrics) and Slide-
Book software (version 4.2.0.27/28; Intelligent Imaging Innovations, Inc.) 
for acquisition. Cells were bathed in buffer A before the addition of 100 µM 
nicotine, and a time-lapse video using simultaneous acquisition was cap-
tured at 1 frame/s for the indicated period. The speed and density of NPY-
mCherry–labeled SGs were measured using SlideBook (version 4.2.0.27/28) 
and ImageJ software. For long-term TIRF imaging, cells were bathed in PSS 
control buffer and imaged at 1 frame/2 s for 40 min after stimulation with 
high K+-PSS buffer. To quantify the density of SGs, the average density of 
40 frames per time point was measured using SlideBook (version 
4.2.0.27/28) and ImageJ software. Particle tracking of NPY-mCherry–labeled 
SGs was performed on previously acquired TIRF images using the spot-
tracking function of IMARIS (Version 7.3.1; Bitplane AG). SGs were 
tracked for 3 min after nicotine stimulation. The spot diameter was 0.48 µm, 
and vesicles were selected based on local contrast thresholding after back-
ground subtraction. Tracking was performed using the built-in autoregres-
sive motion model with maximum displacement of 1 µm per time step and 
a gap size of three frames. MSD was calculated for each vesicle over incre-
menting time intervals and then averaged (Steyer and Almers, 1999). To 
characterize SG mobility, MSD data were fitted to various diffusion mod-
els; best fits were obtained when a confined diffusion model was assumed 
(Saxton, 1993). In this model, the MSD is described as follows and pro-
vides a second order approximation of the SG diffusion within a finite 
space or cage:
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A1 and A2 are constants determined by the cage geometry with A1 = 0.99 
and A2 = 0.85 for circular cages (Saxton, 1993; Saxton and Jacobson, 
1997). D is the diffusion coefficient of a particle within the cage, and r is 
the radius of the circular cage in which an infinitesimally small particle is 
free to diffuse with diffusion coefficient D. Only SGs tracked for >10 con-
secutive frames were considered.
To characterize the MSD of SGs moving toward the plasma mem-
brane, the manual particle-tracking function from SlideBook software was 
used. These SGs can be identified as they appear in the TIRF plane, and 
their fluorescence intensity increases as they approach the plasma mem-
brane. The trajectories of this population of SGs were followed after nico-
tine stimulation for 12–15 s, and the MSD for each track was calculated 
and averaged as stated in the previous paragraph. 40–80 trajectories 
were counted per condition. SGs already tethered in the TIRF plan were not 
included in this analysis.
To examine the possible change in SG movement upon association 
with GFP-MyoVI-full after stimulation, we used the colocalization module of 
SlideBook to identify GFP-MyoVI–positive or –negative NPY-mCherry–positive 
SGs. From the scatter plot obtained, the population of SGs with high fluor-
escence levels for the mCherry channel only was selected and considered 
as GFP-MyoVI–negative SGs. In addition, we also selected a population of 
SGs with high fluorescence levels for both mCherry and GFP. In this group, 
referred as GFP-MyoVI–positive SGs, we predominantly observed only par-
tial colocalization between NPY-mCherry–labeled SGs and GFP-MyoVI, 
with GFP-MyoVI largely juxtapositioned to the SGs. 30–70 SGs were man-
ually tracked for 12 s for each condition, and the MSD was calculated for 
each trajectory.
PP2 and PP3 treatments
PC12 cells expressing the respective myosin VI proteins were washed and 
incubated with DMSO (control), 20 µM PP2, or 20 µM PP3 (EMD Millipore; 
Merck) in complete medium for 30 min at 37°C. NPY-hPLAP release was 
subsequently assayed as described in the NPY-hPLAP release assay section 
in the continued presence of DMSO, 20 µM PP2, or 20 µM PP3. For live-
cell imaging, cells were washed and bathed in buffer A in the presence 
of DMSO, 20 µM PP2, or 20 µM PP3.
supernatants, cells were lysed with 0.2% Triton X-100 to measure total 
NPY-hPLAP. The released and total NPY-hPLAP were measured using the 
chemiluminescent reporter gene assay system (Phospha-Light; Applied Bio-
systems) according to the manufacturer’s instructions, and the results were 
expressed as a percentage of total NPY-hPLAP.
EM
Immunogold labeling. PC12 cells seeded on poly-d-lysine–coated dishes 
were washed in PBS, fixed with 4% paraformaldehyde/PBS for 15 min, 
and quenched with 50 mM NHCl4/PBS for 10 min. They were then perme-
abilized in 0.1% Triton X-100/PBS for 10 min and blocked in 0.2% 
BSA/0.2% fish skin gelatin/PBS for 10 min. Cells were incubated for 60 min 
at room temperature with the anti–myosin VI antibody, washed with PBS, 
and labeled with protein A conjugated to 5-nm gold particles. After labeling, 
cells were fixed with 2.5% glutaraldehyde and contrasted with 1% osmium 
tetroxide and 4% uranyl acetate before dehydration and embedding in 
LX-112 resin.
Correlative EM. PC12 cells expressing GFP-MyoVI-SIfull were seeded 
on gridded poly-d-lysine–coated glass-bottomed culture dishes (MatTek 
Corporation). After 24 h, cells were fixed in 2.5% glutaraldehyde in PBS. 
Bright-field and epifluorescence images were taken using a 10× air objec-
tive on a microscope (Axio Imager; Carl Zeiss). The coordinates of trans-
fected cells were noted before processing for transmission EM as in the 
previous paragraph.
For EM, sections (50 nm) were cut using an ultramicrotome (UC64; 
Leica) and imaged using a transmission electron microscope (model 
1011; JEOL) equipped with a cooled charge-coupled device camera 
(Morada; Olympus). All images were processed using Photoshop CS3 
(Adobe), and figures were compiled with Illustrator CS3 (Adobe).
Confocal microscopy
Cells were imaged with a confocal microscope (LSM510 META; Carl 
Zeiss) using Zen acquisition software (2009 version; Carl Zeiss). Images 
were acquired with a Plan-Apochromat 63× oil immersion objective (NA 
1.4). The pinhole was adjusted to obtain 1 Airy unit for the fluorophore of 
shortest wavelength excitation/emission properties. GFP or Alexa Fluor 
488 fluorescence was detected using an argon laser with an excitation line 
at 488 nm, a 488/561-nm excitation dichroic mirror, and a 505/550-nm 
band pass emission filter. mCherry or Alexa Fluor 546 fluorescence was 
detected using a 561-nm excitation laser (power 0.5–2%), a 488/561-nm 
excitation dichroic mirror, and a 575-nm long pass emission filter. For dual 
color acquisition, images were sequentially acquired in line scan mode 
(average line = 4).
Immunofluorescence confocal microscopy. Untransfected PC12 cells or 
cells transfected with the plasmid of interest seeded on poly-d-lysine–coated 
coverslips were washed in PBS, fixed with 4% paraformaldehyde/PBS for 
30 min on ice, and quenched with 50 mM NHCl4/PBS for 10 min on ice. 
Cells were then permeabilized in 0.1% saponin/2% BSA/PBS for 10 min 
on ice and blocked in 0.2% BSA/0.2% fish skin gelatin/PBS 10 min. Cover-
slips were incubated at 4°C with primary antibodies overnight, washed 
with PBS, and treated with the relevant secondary antibodies for 1 h at 
37°C followed by PBS washing and mounting with ProLong Gold (Molec-
ular Probes; Invitrogen) for confocal imaging. Phalloidin staining (1:500; 
Molecular Probes; Invitrogen) was performed after cell fixation for 1 h at 
room temperature. For colocalization analysis, the Pearson correlation co-
efficient was determined using ImageJ, with the values being expressed as 
the means ± SEM. To determine the area of the GFP-positive structures ob-
served upon GFP-MyoVI-full protein expression in either wild-type or myo-
sin VI knockdown PC12 cells, confocal images of fixed cells were used, 
and the area was measured using ImageJ. The results display the average 
of 150 structures for each condition.
Live-cell imaging for activity-dependent recruitment of NPY-mCherry–
positive vesicles around GFP-MyoVI–positive structures. Cells coexpressing 
NPY-mCherry and the respective GFP-MyoVI protein were washed and 
bathed in buffer A (145 mM NaCl, 5 mM KCl, 1.2 mM Na2HPO4, 10 mM 
glucose, and 20 mM Hepes-NaOH, pH 7.4) containing 2 mM Ca2+ at 
room temperature. Z stacks were taken over 10 min under control condi-
tions and after 100 µM nicotine (Sigma-Aldrich) stimulation. Scan speed 
was 22 s/stack, and pinholes were adjusted to obtain an optical slice of 
2 µm. Image analysis was performed using ImageJ software using raw 
nonsaturated images. A region of interest was drawn around GFP-MyoVI–
positive structures, and the mean intensity was measured for both the GFP 
and mCherry channels for the duration of the video. Both intensities were 
expressed as a percentage of initial intensity and as means ± SEM of three 
independent experiments.
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Bioinformatics analysis
Protein sequence alignments were performed using BLAST (Basic Local 
Alignment Search Tool). Phosphorylation sites and kinase-specific phos-
phorylation sites in myosin VI were predicted using NetPhos 2.0 (Center 
for Biological Sequence Analysis) and NetPhosK 1.0 (Center for Biological 
Sequence Analysis), respectively.
Statistical analysis
All experiments were repeated at least three times. Data analysis was per-
formed using unpaired, two-tailed Student’s t tests, unless stated otherwise, 
and data were considered significant at P < 0.05. Values are expressed 
as means ± SEM, and the level of significance is designated in the figure 
legend as follows: *, P < 0.05; **, P < 0.01; ***, P < 0.001.
Online supplemental material
Fig. S1 shows that myosin VI knockdown does not affect SG biogenesis or 
Golgi complex organization. Fig. S2 highlights the defect in SG replenish-
ment near the plasma membrane in myosin VI knockdown PC12 cells. Fig. S3 
shows that neither endocytic nor constitutive exocytic pathways are affected 
by the expression of GFP-MyoVI-full protein. Fig. S4 shows that GFP-MyoVI-
full expression reorganizes SGs in an F-actin–dependent manner. Fig. S5 
demonstrates that the potentiation of NPY-evoked release mediated by 
myosin VI SI requires c-Src kinase activity. Table S1 shows a selection 
of proteins identified using MALDI-TOF/TOF after pull-down experiment 
using purified SG. Video 1 (related to Fig. 4 E) shows that myosin VI SI 
restricts the movement of SGs near the plasma membrane. Video 2 (related 
to Fig. 4 F) shows that the myosin VI NI isoform lacks the ability to cage 
SG movement at the plasma membrane. Online supplemental material is 
available at http://www.jcb.org/cgi/content/full/jcb.201204092/DC1. 
Additional data are available in the JCB DataViewer at http://dx.doi 
.org/10.1083/jcb.201204092.dv.
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